| | |

Should Mesothelioma Patients Take Aspirin for Cancer Survival?

ByAlex Strauss
aspirin for cancer survival

There is new evidence supporting the use of low-dose aspirin for cancer survival. 

The evidence comes from two new retrospective studies. The first involved patients with head and neck cancer. The second focused on patients with early-stage non-small cell lung cancer (NSCLC). NSCLC is similar to mesothelioma in many ways. 

Mesothelioma is an aggressive cancer that is often fatal within a year of diagnosis. Based on the new findings, some mesothelioma patients may consider talking to their doctors about aspirin for cancer survival

Anti-Inflammatories and Cancer Treatment

Anti-inflammatory drugs like aspirin can cut the risk for heart disease and heart attack. But research led by the Roswell Park Cancer Center shows they may have similar benefits for people with cancers like pleural mesothelioma.

Non-steroidal anti-inflammatories (NSAIDs) reduce inflammation and have anti-platelet properties. Inflammation may contribute to the start and growth of malignant mesothelioma and other cancers. 

The new studies are among the first to show a link to aspirin for cancer survival for patients with either lung cancer or head and neck cancer. They were presented recently at the American Society for Therapeutic Radiation Oncology annual meeting in Chicago.

Radiation, Chemotherapy, and Aspirin for Cancer Survival

In the lung cancer study, 164 patients with early-stage non-small cell lung cancer had a type of precision radiotherapy called SBRT. Some mesothelioma patients also undergo SBRT. Some of the lung cancer patients took a daily baby aspirin and some did not.

The patients who took aspirin for cancer survival lived nearly five months longer than those who did not. At two years, 57 percent of the aspirin group was still living versus 48 percent of the non-aspirin patients. 

“This is an exciting new avenue we are researching in other cancer types and designing new prospective clinical trials for,” says lead researcher Anurag Singh, MD.

The second study focused on 460 patients who had chemotherapy and conventional radiotherapy for head and neck cancer. (This treatment combination is also used for people with pleural mesothelioma.)

In the group that took aspirin for cancer survival, there was an 8 percent survival advantage at 5 years. Patients on aspirin lived longer, even though aspirin did not seem to impact the effectiveness of their cancer treatment.

“These studies provide further support for a growing body of literature that demonstrates a benefit for use of non-steroidal anti-inflammatory drugs, such as aspirin, by cancer patients,” says Gregory Hermann, MD, of Roswell Park. “Although clinical trials are needed to make a definitive recommendation, we encourage patients to have a discussion with their doctor regarding the risks and potential benefits of aspirin use.

There is already some evidence for aspirin use in mesothelioma. A 2015 mesothelioma study showed that aspirin “markedly reduced malignant mesothelioma growth” in mice. The treated mice also lived longer. 

About 2,500 Americans receive a mesothelioma diagnosis every year. Most of them have worked in an asbestos industry.

Sources:

Hermann, G, et al, “Concurrent Aspirin Use Is Associated with a Trend in Improved Overall Survival in Early Stage Lung Cancer Patients Undergoing SBRT: A Retrospective Review”, September 15, 2019. ASTRO Presentation, https://eventscribe.com/2019/ASTRO/ajaxcalls/PresentationInfo.asp?efp=TE5aWFlKWEY5MDg1&PresentationID=567107&rnd=0.8335098

Iovoli, AJ, et al, “Non-Steroidal Anti-Inflammatory Drug Use Is Associated with Improved Survival in Head and Neck Cancer: A Retrospective Review”, September 16, 2019, ASTRO Presentation, https://eventscribe.com/2019/ASTRO/ajaxcalls/PresentationInfo.asp?efp=TE5aWFlKWEY5MDg1&PresentationID=566626&rnd=0.2370917

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Ape Virus Shrinks Mesothelioma Tumors in Lab

    ByAlex Strauss

    A virus that causes leukemia in gibbon apes may have the power to help fight malignant mesothelioma in people. Gibbon ape leukemia virus (GALV) has been tested for years as a viral vector, a carrier of therapeutic genetic information, in the treatment of various human illnesses, including cancer. A new study in Japan compared GALV with a leukemia virus derived from mice to see which carrier communicated most efficiently with mesothelioma cells. While both types of viruses replicated in most of the mesothelioma cell lines tested, the mouse-derived virus was not effective in a mesothelioma cell line called ACC-MESO-1. In this cell line, only the GALV spread efficiently both in culture and in mice that had been given human mesothelioma…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    ByAlex Strauss

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | |

    A Second-Line Option for Mesothelioma?

    ByAlex Strauss

    Although survival was not significantly extended, the chemotherapy drug vinorelbine might be a treatment option for mesothelioma patients whose cancer has returned after first-line chemotherapy with pemetrexed. A new study on vinorelbine as a second-line treatment finds that the drug is “moderately active” in mesothelioma patients who were initially treated with pemetrexed-based chemotherapy. Pemetrexed (Alimta), along with a platinum-based drug like cisplatin, is the primary first-line drug therapy for mesothelioma. But vinorelbine is gaining attention as a possible option for mesothelioma, in part because it is available in a less expensive generic form. In “Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma”, the Italian authors detail the results of their study on 59 patients with unresectable pleural mesothelioma.  These patients…

  • | |

    Repeat HIPEC Improves Mesothelioma Survival

    ByAlex Strauss

    If one cytoreductive surgery and HIPEC procedure for mesothelioma is good, subsequent treatments may be even better. That is the central message of research conducted at the Moffitt Cancer Center in Florida. The study’s aim was to assess overall survival among peritoneal mesothelioma patients who had not just one, but two or more rounds of heated intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery. The cytoreduction/HIPEC approach has become popular for peritoneal mesothelioma, a treatment-resistant cancer of abdominal membranes caused by asbestos. Cytoreductive surgery involves removing as much of the mesothelioma tumor as possible from the abdomen. Because the shape and spreading pattern of mesothelioma tumors make complete cytoreduction difficult, the surgery is often followed by a rinse with a heated solution…